ARA - American Renal Associates Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Net Income4,857-38518,84516,197
Operating Activities, Cash Flows Provided By or Used In
Adjustments To Net Income86,826121,80077,49179,976
Changes In Accounts Receivables1,465-4,208-5,987-1,690
Changes In Liabilities2,2948,556519-5,326
Changes In Inventories11-385538-376
Changes In Other Operating Activities-6,57110,3767,455-1,871
Total Cash Flow From Operating Activities128,547172,211133,595118,259
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-36,073-61,432-46,273-39,849
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-35,303-65,939-48,915-44,935
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid-8,729-30,241-30,241-30,241
Sale Purchase of Stock----
Net Borrowings-9,846-144,65319,26712,236
Other Cash Flows from Financing Activities-106,344-96,518-75,092-61,576
Total Cash Flows From Financing Activities-122,539-96,344-55,167-44,719
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-29,2959,92829,51328,605